Business Context and Reporting Period
Company: HCM III Acquisition Corp. (a Cayman Islands exempted corporation and "blank check" company).
Reporting Period: Quarter ended June 30, 2025 (Inception: April 15, 2025).
Status: Pre-IPO formation phase. The company was incorporated to effect a business combination but had not commenced operations or selected a target as of June 30, 2025. The Initial Public Offering (IPO) was consummated on August 4, 2025, subsequent to the reporting period.
Key Financial Metrics (Inception through June 30, 2025)
| Metric | Value |
|---|---|
| Total Assets | $417,682 |
| Total Liabilities | $440,227 |
| Shareholder's Deficit | $(22,545) |
| Net Loss | $(47,545) |
| Cash and Cash Equivalents | $0 |
| Working Capital Deficit | $(420,227) |
| Promissory Note (Related Party) | $227,800 |
| Deferred Offering Costs | $397,682 |
Material Changes and Subsequent Events
The financial statements reflect a pre-IPO entity with no operating revenue. Significant capital events occurred subsequent to the June 30, 2025 balance sheet date:
- IPO Closing: On August 4, 2025, the company consummated an IPO of 25,300,000 units at $10.00 per unit, including the full exercise of the underwriters' over-allotment option. Gross proceeds totaled $253,000,000.
- Trust Account: $253,000,000 was deposited into a Trust Account.
- Private Placement: Simultaneously, 4,266,667 Private Placement Warrants were sold to the Sponsor and Cantor Fitzgerald & Co. for $6,400,000.
- Debt Repayment: The related-party promissory note outstanding at June 30 ($227,800) was repaid on August 4, 2025.
- Liquidity Post-IPO: As of August 4, 2025, the company held $1,306,160 in cash and had a working capital of $1,269,265.
Outlook, Risks, and Contingencies
Business Combination Timeline: The company has 24 months from the IPO closing (August 4, 2025) to complete a business combination. If unsuccessful, the company will liquidate and redeem public shares.
Transaction Costs: Total transaction costs amounted to $17,106,910, comprising a $4,400,000 cash underwriting fee, a $12,045,000 deferred underwriting fee, and $661,910 in other offering costs.
Risk Factors:
- Geopolitical Instability: Risks associated with the Russia-Ukraine and Israel-Hamas conflicts could impact global markets and the ability to identify or complete a target.
- Going Concern: Prior to the IPO, the company had no cash and relied on related-party loans. Management believes post-IPO proceeds are sufficient for operations for one year.
- Warrant Redemption: Public warrants may be redeemed if the Class A share price exceeds $18.00 for 20 trading days within a 30-day period post-business combination.
Investor Verification Checklist
- IPO Proceeds Allocation: Verify the exact amount remaining in the Trust Account after the deduction of the $4.4M cash underwriting fee and other immediate costs.
- Deferred Fees: Confirm the $12,045,000 deferred underwriting fee obligation and its impact on net cash available for the business combination.
- Related Party Agreements: Review the Administrative Services Agreement ($15,000/month) and the potential for Working Capital Loans (up to $1.5M convertible to warrants).
- Founder Shares: Note that 8,433,333 Class B shares are held by the Sponsor, which convert to Class A shares at a 1:1 ratio (subject to anti-dilution adjustments) upon business combination.
- Redemption Rights: Understand that public shareholders may redeem shares for their pro-rata share of the Trust Account (approx. $10.00/share) upon the completion of a business combination.